Financial statements Improdex

Cash flow statement of Improdex

Company age:
Age:
3 y. 10 m. 4 d.
Share capital:
Share capital:
500 000 PLN

Cash inflows of IMPRODEX

Year
2021
2022
2023
Net cash from operating expenses 15 054 882,33 14 672 150,99 25 073 027,00
Net cash flow from investing activities -7 135 568,82 -4 495 535,12 -4 220 791,40
Net cash flow from financial activities -5 031 687,80 -7 915 710,90 -8 021 565,88
Total net cash flow 2 887 625,71 2 260 904,97 12 830 669,72
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.